author-photo

J. Guigay

Institut Gustave Roussy

257

Papers

5897

Citations

Citation Trend

Filter By

Papers (188) Sort By

Journal Conference Others

775P Tremelimumab (T) + durvalumab (D) combined with metronomic oral vinorelbine (MOV): Results of the recurrent cervical cancer (RCC) cohort of the MOVIE study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Molecular genetics of head and neck squamous cell carcinoma

2019 Current Opinion in Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck

2019 Current Opinion in Oncology
Show All
- Source
- Cite
- Save
Citations (14)
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (38)
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (32)
Two-year Update From CheckMate 141: Outcomes With Nivolumab (Nivo) vs Investigator's Choice (IC) in Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the Overall Population and PD-L1 Subgroups

2018 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (7)
Abstract CT116: Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
92PNext-generation sequencing reveals high intra-individual molecular concordance between primary head and neck tumors and matched local or distant recurrences

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.

2018 World Journal of Surgery
Show All
- Source
- Cite
- Save
Citations (15)
Abstract 4548: Host immunogenetics and hyperprogression under PD1/PD-L1 checkpoint inhibitors

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)